KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Amortization - Intangibles: 2020-2021

Historic Amortization - Intangibles for Aurinia Pharmaceuticals (AUPH) over the last 3 years, with Dec 2021 value amounting to $500,000.

  • Aurinia Pharmaceuticals' Amortization - Intangibles rose 25.63% to $500,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $2.1 million, marking a year-over-year increase of 57.99%. This contributed to the annual value of $2.1 million for FY2021, which is 61.54% up from last year.
  • Aurinia Pharmaceuticals' Amortization - Intangibles amounted to $500,000 in Q4 2021, which was down 3.29% from $517,000 recorded in Q3 2021.
  • In the past 5 years, Aurinia Pharmaceuticals' Amortization - Intangibles ranged from a high of $536,000 in Q2 2021 and a low of $300,000 during Q1 2020.
  • Its 2-year average for Amortization - Intangibles is $423,750, with a median of $449,000 in 2020.
  • Data for Aurinia Pharmaceuticals' Amortization - Intangibles shows a peak YoY spiked of 78.67% (in 2021) over the last 5 years.
  • Aurinia Pharmaceuticals' Amortization - Intangibles (Quarterly) stood at $398,000 in 2020, then rose by 25.63% to $500,000 in 2021.
  • Its Amortization - Intangibles was $500,000 in Q4 2021, compared to $517,000 in Q3 2021 and $536,000 in Q2 2021.